FDA drops efficacy requirement for orphan devices
This article was originally published in Clinica
Executive Summary
The US FDA has eliminated the efficacy requirement for certain devices. Manufacturers of "orphan" devices - those intended to treat rare conditions - need only show that their products are safe, "have a probable benefit" and will not expose patients to "significant" or "unreasonable" risk.